TABLE 2.
Day after infection | (B6 × 129)F1 mice
|
CD40L−/− mice
|
||||||
---|---|---|---|---|---|---|---|---|
% IFN-γ+ CD8+ cellsb
|
CD4+ Thp frequencyc
|
% IFN-γ+ CD8+ cells
|
CD4+ Thp frequency
|
|||||
p56 | p79 | 600 PFU | 10,000 PFU | p56 | p79 | 600 PFU | 10,000 PFU | |
7 | 0.52 ± 0.18 | 0.42 ± 0.17 | 148 ± 21 | ND | 0.55 ± 0.07 | 0.49 ± 0.18 | 6,408 ± 4,973 | ND |
16 | 2.68 ± 0.86 | 4.87 ± 1.07 | 80 ± 68 | 128 ± 144 | 1.77 ± 1.00 | 2.80 ± 1.64 | 6,102 ± 6,982 | 3,234 ± 2,033 |
35 | 0.91 ± 0.15 | 1.67 ± 0.92 | ND | ND | 1.63 ± 0.62 | 4.03 ± 2.97 | ND | ND |
The (B6 × 129)F1 and CD40L−/− mice were infected i.n. with 600 PFU of γHV-68, and single-cell spleen suspensions were analyzed for virus-specific CD8+ (p56 or p79) or CD4+ T (Thp) cells. All values are means ± standard deviations for four or five mice. ND, not done.
Determined by flow cytometric analysis of spleen populations following 6 h of stimulation with the H-2Db-restricted p56 peptide or the H-2Kb-restricted p79 peptide in the presence of brefeldin A. The lymphocytes were fixed and stained for the presence of IFN-γ.
Reciprocal of the CD4+ Thp frequency, determined in a 48-h ELISpot assay. The Thp frequencies were not obviously modified by infecting the mice with a higher dose of virus.